Hemostasis after traumatic liver injury can be extremely difficult to obtain, particularly in coagulopathic patients who have suffered extensive liver damage. We determined the ability of a fibrin glue preparation (FG) to terminate ongoing bleeding using a new, clinically relevant porcine model of complex hepatic injury. Anesthetized swine (n = 6, 18 to 19 kg) received an external blast to the right upper abdomen and were immediately anticoagulated with intravenous heparin (200 u/kg). Uncontrolled hemorrhage from blast continued from time of injury (t = 0 minutes) to t = 15 minutes. Lactated Ringer's solution was infused to keep mean arterial pressure (MAP) > 80 mm Hg until the end ofexperiment (t = 90 minutes). Animals underwent routine surgical techniques to control bleeding, and FG was employed in the event these measures failed. Estimated blood loss and fluid resuscitation volume were measured. Serial MAP, arterial base excess, and temperature were recorded. Animals were severely injured with significant blood loss prior to laparotomy (26 ± 6 cc/kg) and during routine surgical efforts to arrest hemorrhage (11 ± 2 cc/kg). Bleeding could not be controlled with standard techniques in any animal. FG rapidly controlled hemorrhage and eliminated the needfor packing. Re-bleeding was noted in only one animal (portal vein injury). FG can control severe hepatic hemorrhage when surgical techniquesfaiL Further work in the clinical arena is warranted to determine the potential benefits ofFG in arresting hemorrhage in hemodynamically unstable coagulopathic patients with complex hepatic injuries.
INTRODUCTION
Liver injuries have an associated mortality of approximately 25 percent with exsanguination being the primary cause of death [1, 2] . Hemostasis in these patients is hindered by the development of coagulopathy, which results from hypothermia, dilution of clotting factors, and thrombocytopenia. Control of bleeding in severe liver injuries frequently requires packing, with definitive repair delayed for hours while the coagulopathy is corrected [3] . New methods for obtaining rapid hemostasis in this setting would obviate the need for second-look procedures and represent a significant addition to the surgeon's a To whom all correspondence should be addressed: Stephen M. Cohn armamentarium. Fibrin glue (FG)b has been effective in arresting hemorrhage in animal models of hepatic injury [4] [5] [6] [7] . Unfortunately, current [9] . At full inspiration, the endotracheal tube was clamped prior to inducing the external blast to the abdominal wall that generated the Grade III liver laceration, which resembles the clinical scenario (t = 0 minutes). Injuries were reproducible, inducing an area of deep contusion, 4 [10] . At Cushing's suggestion, Grey performed experiments with fibrin extracted from sheep's blood to control bleeding from skin and cerebral lacerations in cats and dogs [11] . Harvey converted bovine fibrin into a paper-like hemostatic material, which he used in wound repair and intestinal anastomoses [12] . FG was first used by plastic surgeons in nerve anastomoses more than 50 years ago [13] . In 1944, Cronkite reported the use of thrombin and fibrinogen together as skin grafting agents in a manner similar to the present day [14] . FG was "re-discovered" in the 1970s with the development of microsurgical techniques. During the past two decades, FG has been used increasingly as a sealant or hemostatic agent in many areas of surgery [8] .
The mechanism of action of FG involves the stimulation of natural clotting factors (Figure 1 ). FG is formed by multiple components such as fibrinogen, factor XIIIa, thrombin, calcium chloride and aprotinin. Fibrinogen is converted to fibrin by thrombin; and fibrin molecules polymerize in the presence of calcium and factor XIII to form a stable fibrin clot. FG is eventually metabolized without residue [6] .
Experimental work has supported the notion that FG is beneficial in arresting hemorrhage from visceral injury. Jakob and his group were among the first to show fibrin sealant to be beneficial in arresting hemorrhage during hepatic injury [5] . In anticoagulated rats with liver damage, they demonstrated an improvement in survival when conventional suture repair techniques were compared with fibrin impregnated collagen. The fibrin sealant was completely absorbed without foreign body reaction or fibrosis at 28 days [5] . Kram [7] . Pigs receiving standard methods required packing in six of seven animals, while none of FG treated animals (seven of seven) required packing. Estimated blood loss was 875 ± 265 cc in the control group and decreased significantly to 300 ± 59 cc in the FG treated animals. In recent studies, Holcomb et al. has shown that a fibrin-based foam could reduce blood loss compared to a placebo foam in a murine model where the median hepatic lobe was excised [15] . This group also studied a porcine model of Grade V liver injury using a clamping technique to induce the lesion. The initial study showed a 51 percent decrease in the amount of blood loss with a dry fibrin sealant dressing (DFSD) over standard packing [16] . These results, however, did not reach statistical significance. A follow-up study using a similar model showed a one-hour survival of 83 percent in the DFSD group and 0 percent in routine packing and placebo groups [17] .
FG may have particular clinical utility in the setting of abdominal trauma [8] , but there is limited data on FG utility in liver injury. Kram et al. reported successful repair with FG after hepatic injury in eight coagulopathic patients [18] . Ochsner and coworkers had similar success with hepatic and splenic hemostasis after trauma in eight coagulopathic patients [19] . Recent case reports have attributed hypotensive episodes during intraparenchymal injection in deep liver injuries to FG [20, 21] . These adverse reactions were thought to be secondary to intravascular injection of FG prepared with bovine thrombin, however, these secondary effects were not reported with this new human thrombin product. The studies above represent the sum of animal and clinical research regarding the use of FG in the setting of hepatic hemorrhage.
Our investigation examined the impact of FG upon hemostasis in a model of uncontrolled hemorrhage from liver injury. This model of liver contusion grossly resembles the clinical entity and is similar to one used in our previous study [7] . The use of a porcine model is advantageous because of the similar hepatic anatomy and large animal size that allows use of instruments and techniques from clinical practice. This study differs from the previous one in several ways. It utilizes a newer, FDA approved viral-free FG preparation increasing the clinical relevance of the experiment. In our previous study, control pigs were injured and received only conventional treatment. This resulted in a high mortality during the course of the experiment for the control group. In the current study, animals acted as their own controls.
There are several limitations to the study. Firstly, although our goal was to simulate a patient's course following a blunt hepatic injury, anesthetizing the animals was necessary to allow for completion of all of the procedures outlined in our protocol. The dose of pentobarbital used in the study was determined from previous experiments [7, 9] and reflects the minimal amount needed to keep the animals sedated throughout the experiment. This may have contributed to the drop in MAP after injury and high resuscitation volumes, but the animals were allowed to equilibrate under anesthesia without any manipulation for 15 minutes before injury. Second, in order to replicate the coagulopathy that individuals experience as a result of remaining in the field for extended periods of time, all of the pigs received a large dose of intravenous heparin. Heparin was given to increase blood loss as well as make the animals less likely to respond to either packing or FG. The supra-therapeutic dose of heparin induces a severe coagulopathy in excess of that necessary for clinical anticoagulation. Although hypothermia was not severe enough to induce a coagulation dysfunction, there are significant numbers of patients on anticoagulant medication or having an underlying high degree of liver dysfunction that place them in an anticoagulation state. Third, despite our attempts to create a hepatic injury of a specific size and depth, the differences in respective anatomies of the pigs prevented perfectly reproducible contusions between animals. One pig sustained a portal vein injury, which was unrecognized and bled massively following laparotomy. Also, the nature of the injuries was such that they required emergent repair during the laparotomy and precluded any precise measurement of the size of the contused area.
Fourth, comparison of blood loss and resuscitation requirements after injury was limited by the techniques used and variability among animals. The use of lap pads to measure blood loss, while not precise, allows comparison of initial hemorrhage volumes among the animals. The amount of blood at re-laparotomy in all but one animal was negligible. Our fixed volume resuscitation of 20 cc/kg may have been excessive but reflects an amount routinely used in trauma patients. The decision was made to maintain MAP greater than 80 mmHg in an attempt to replicate the typical clinical scenario.
In a heparinized porcine model of complex hepatic injury, FG controlled hemoffhage after failure of conventional surgical techniques. FG quickly established a hemostatic seal over the bleeding areas. Most importantly, the use of FG permitted safe completion of the abdominal operation without the need for packing of parenchymal injuries. Further work in the clinical arena is warranted to determine the potential benefits of FG in arresting hemorrhage in the coagulopathic trauma patient with complex hepatic injuries.
